Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002315758 | SCV000663203 | uncertain significance | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2021-09-03 | criteria provided, single submitter | clinical testing | The c.7717C>T (p.R2573C) alteration is located in exon 52 (coding exon 52) of the NF1 gene. This alteration results from a C to T substitution at nucleotide position 7717, causing the arginine (R) at amino acid position 2573 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV001040889 | SCV001204480 | likely benign | Neurofibromatosis, type 1 | 2024-10-18 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001040889 | SCV002561129 | uncertain significance | Neurofibromatosis, type 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002491121 | SCV002790684 | uncertain significance | Neurofibromatosis, familial spinal; Juvenile myelomonocytic leukemia; Neurofibromatosis, type 1; Neurofibromatosis-Noonan syndrome; Café-au-lait macules with pulmonary stenosis | 2022-01-07 | criteria provided, single submitter | clinical testing | |
Gene |
RCV004777741 | SCV005388536 | uncertain significance | not provided | 2024-04-12 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 25486365) |